Clinical Trial Update: Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating multiple-dose exposure to three oral nicotine replacement products in individuals with tobacco use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Oral nicotine replacement products (unspecified) (nicotine replacement therapy, oral)

Snippet

Sponsor: McNeil AB | Conditions: Tobacco Dependence | Phase 1 | Status: COMPLETED